Kyowa Kirin

Kyowa Kirin is a pharmaceutical company that specializes in the development and commercialization of innovative biopharmaceuticals. The company focuses on the areas of oncology, nephrology, and rare diseases. They have a strong research and development pipeline, with a particular emphasis on biologics and other advanced therapies. Kyowa Kirin also has a range of drugs targeting various diseases such as multiple myeloma, renal cell carcinoma, and certain rare genetic disorders. The company was founded in 1949 and continues to be a leader in the field of biopharmaceutical research and development.